FindTrial
Sign In

Associations of novel inflammatory biomarkers with clinical outcomes in Patients With acute ST segment elevation myocardial infarction (STEMI)

Associations of novel inflammatory biomarkers with clinical outcomes in Patients With acute ST segment elevation myocardial infarction (STEMI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049424
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-07-28
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ST segment elevation myocardial infarction

Interventions

Case series:None

Sponsors

First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. STEMI patients aged >=18 years or healthy individuals known to have no cardiovascular disease; 2. Voluntarily join this research; 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.?ST??????? 2.??????? 3.???????; 4.????; 5.??????; 6.?????; 7.???????; 8.????; 9.3??????????; 10.??; 11.???????; 12.??????; 13.????????????

Design outcomes

Primary

MeasureTime frame
novel inflammatory biomarkers;Major adverse cardiac events;—

Countries

China

Contacts

Public ContactZhang Bo

First Affiliated Hospital of Dalian Medical University

zhangbo2674@163.com+86 18098875726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026